BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sugiyama M, Izumisato Y, Abe N, Masaki T, Mori T, Atomi Y. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg. 2003;90:1244-1249. [PMID: 14515294 DOI: 10.1002/bjs.4265] [Cited by in Crossref: 338] [Cited by in F6Publishing: 305] [Article Influence: 17.8] [Reference Citation Analysis]
Number Citing Articles
1 Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. J Clin Gastroenterol 2006;40:856-62. [PMID: 17016145 DOI: 10.1097/01.mcg.0000225609.63975.6f] [Cited by in Crossref: 70] [Cited by in F6Publishing: 58] [Article Influence: 4.7] [Reference Citation Analysis]
2 Winner M, Epelboym I, Remotti H, Lee JL, Schrope BA, Chabot JA, Allendorf JD. Predictors of Recurrence in Intraductal Papillary Mucinous Neoplasm: Experience with 183 Pancreatic Resections. J Gastrointest Surg 2013;17:1618-26. [DOI: 10.1007/s11605-013-2242-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
3 Fritz S, Warshaw AL, Thayer SP. Management of mucin-producing cystic neoplasms of the pancreas. Oncologist 2009;14:125-36. [PMID: 19211618 DOI: 10.1634/theoncologist.2008-0200] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
4 Nara S, Onaya H, Hiraoka N, Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T. Preoperative evaluation of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas: clinical, radiological, and pathological analysis of 123 cases. Pancreas. 2009;38:8-16. [PMID: 18665010 DOI: 10.1097/mpa.0b013e318181b90d] [Cited by in Crossref: 62] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
5 Tran Cao HS, Kellogg B, Lowy AM, Bouvet M. Cystic neoplasms of the pancreas. Surg Oncol Clin N Am 2010;19:267-95. [PMID: 20159515 DOI: 10.1016/j.soc.2009.11.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
6 Murakami Y, Uemura K, Hayashidani Y, Sudo T, Sueda T. Predictive Factors of Malignant or Invasive Intraductal Papillary-Mucinous Neoplasms of the Pancreas. J Gastrointest Surg 2007;11:338-44. [DOI: 10.1007/s11605-006-0069-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
7 Waters JA, Schmidt CM. Intraductal papillary mucinous neoplasm--when to resect? Adv Surg 2008;42:87-108. [PMID: 18953811 DOI: 10.1016/j.yasu.2008.03.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
8 Jones NB, Hatzaras I, George N, Muscarella P, Ellison EC, Melvin WS, Bloomston M. Clinical factors predictive of malignant and premalignant cystic neoplasms of the pancreas: a single institution experience. HPB (Oxford). 2009;11:664-670. [PMID: 20495634 DOI: 10.1111/j.1477-2574.2009.00114.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
9 Das A, Wells CD, Nguyen CC. Incidental Cystic Neoplasms of Pancreas: What Is the Optimal Interval of Imaging Surveillance. The American Journal of Gastroenterology 2008;103:1657-62. [DOI: 10.1111/j.1572-0241.2008.01893.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 4.7] [Reference Citation Analysis]
10 Reddy S, Wolfgang CL. Benign pancreatic tumors. Surg Clin North Am 2007;87:1359-78, viii. [PMID: 18053836 DOI: 10.1016/j.suc.2007.08.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
11 Volkan Adsay N. Cystic lesions of the pancreas. Mod Pathol. 2007;20 Suppl 1:S71-S93. [PMID: 17486054 DOI: 10.1038/modpathol.3800706] [Cited by in Crossref: 122] [Cited by in F6Publishing: 90] [Article Influence: 8.1] [Reference Citation Analysis]
12 Tanaka M, Chari S, Adsay V, Carlos Castillo F, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S. International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas. Pancreatology 2006;6:17-32. [DOI: 10.1159/000090023] [Cited by in Crossref: 1440] [Cited by in F6Publishing: 1227] [Article Influence: 90.0] [Reference Citation Analysis]
13 Garcea G, Ong SL, Rajesh A, Neal CP, Pollard CA, Berry DP, Dennison AR. Cystic lesions of the pancreas. A diagnostic and management dilemma. Pancreatology. 2008;8:236-251. [PMID: 18497542 DOI: 10.1159/000134279] [Cited by in Crossref: 132] [Cited by in F6Publishing: 108] [Article Influence: 9.4] [Reference Citation Analysis]
14 Weinberg BM, Spiegel BM, Tomlinson JS, Farrell JJ. Asymptomatic pancreatic cystic neoplasms: maximizing survival and quality of life using Markov-based clinical nomograms. Gastroenterology. 2010;138:531-540. [PMID: 19818780 DOI: 10.1053/j.gastro.2009.10.001] [Cited by in Crossref: 80] [Cited by in F6Publishing: 65] [Article Influence: 6.2] [Reference Citation Analysis]
15 Niiya F, Ohike N, Norose T, Takano Y, Azami T, Kobayashi T, Maruoka N, Wakabayashi T, Matsuo K, Tanaka K, Nagahama M. Can the location of the mural nodule indicate benign or malignant in branch duct-type intraductal papillary mucinous neoplasm of the pancreas? Pancreatology 2020;20:1379-85. [PMID: 32873485 DOI: 10.1016/j.pan.2020.08.006] [Reference Citation Analysis]
16 Roch AM, Schmidt CM. Management of Mixed-Type Intraductal Papillary Mucinous Neoplasm. Advances in Surgery 2016;50:1-15. [DOI: 10.1016/j.yasu.2016.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Zhang J, Wang PJ, Yuan XD. Correlation between CT patterns and pathological classification of intraductal papillary mucinous neoplasm. Eur J Radiol. 2010;73:96-101. [PMID: 19008065 DOI: 10.1016/j.ejrad.2008.09.035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 0.7] [Reference Citation Analysis]
18 Woo SM, Ryu JK, Lee SH, Yoon WJ, Kim Y, Yoon YB. Branch duct intraductal papillary mucinous neoplasms in a retrospective series of 190 patients. British Journal of Surgery 2009;96:405-11. [DOI: 10.1002/bjs.6557] [Cited by in Crossref: 76] [Cited by in F6Publishing: 70] [Article Influence: 5.8] [Reference Citation Analysis]
19 Abdeljawad K, Vemulapalli KC, Schmidt CM, Dewitt J, Sherman S, Imperiale TF, Al-Haddad M. Prevalence of malignancy in patients with pure main duct intraductal papillary mucinous neoplasms. Gastrointest Endosc. 2014;79:623-629. [PMID: 24094923 DOI: 10.1016/j.gie.2013.08.024] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
20 Koshita S, Fujita N, Noda Y, Kobayashi G, Ito K, Horaguchi J, Kanno Y, Ogawa T, Masu K, Michikawa Y, Iwashita Y, Sawai T, Uzuki M, Fujishima F. Invasive carcinoma derived from "flat type" branch duct intraductal papillary mucinous neoplasms of the pancreas: impact of classification according to the height of mural nodule on endoscopic ultrasonography. J Hepatobiliary Pancreat Sci 2015;22:301-9. [PMID: 25488889 DOI: 10.1002/jhbp.199] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
21 Ogawa T, Horaguchi J, Fujita N, Noda Y, Kobayashi G, Ito K, Koshita S, Kanno Y, Masu K, Sugita R. Diffusion-weighted magnetic resonance imaging for evaluating the histological degree of malignancy in patients with intraductal papillary mucinous neoplasm. J Hepatobiliary Pancreat Sci. 2014;21:801-808. [PMID: 25082473 DOI: 10.1002/jhbp.135] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
22 Hutchins G, Draganov PV. Diagnostic Evaluation of Pancreatic Cystic Malignancies. Surgical Clinics of North America 2010;90:399-410. [DOI: 10.1016/j.suc.2010.01.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
23 European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms. Gut. 2018;67:789-804. [PMID: 29574408 DOI: 10.1136/gutjnl-2018-316027] [Cited by in Crossref: 380] [Cited by in F6Publishing: 283] [Article Influence: 95.0] [Reference Citation Analysis]
24 Nakata K, Nagai E, Ohuchida K, Aishima S, Hayashi A, Miyasaka Y, Yu J, Mizumoto K, Tanaka M, Tsuneyoshi M. REG4 is associated with carcinogenesis in the 'intestinal' pathway of intraductal papillary mucinous neoplasms. Mod Pathol. 2009;22:460-468. [PMID: 19136934 DOI: 10.1038/modpathol.2008.205] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
25 Jana T, Shroff J, Bhutani MS. Pancreatic cystic neoplasms: Review of current knowledge, diagnostic challenges, and management options. J Carcinog. 2015;14:3. [PMID: 25821410 DOI: 10.4103/1477-3163.153285] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
26 Ogawa H, Itoh S, Ikeda M, Suzuki K, Naganawa S. Intraductal papillary mucinous neoplasm of the pancreas: assessment of the likelihood of invasiveness with multisection CT. Radiology. 2008;248:876-886. [PMID: 18632526 DOI: 10.1148/radiol.2482071578] [Cited by in Crossref: 88] [Cited by in F6Publishing: 72] [Article Influence: 6.3] [Reference Citation Analysis]
27 Kobayashi K, Sadakari Y, Ohtsuka T, Takahata S, Nakamura M, Mizumoto K, Tanaka M. Factors in Intraductal Papillary Mucinous Neoplasms of the Pancreas Predictive of Lymph Node Metastasis. Pancreatology 2011;10:720-5. [DOI: 10.1159/000320709] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
28 Tanno S, Nakano Y, Koizumi K, Sugiyama Y, Nakamura K, Sasajima J, Nishikawa T, Mizukami Y, Yanagawa N, Fujii T, Okumura T, Obara T, Kohgo Y. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms. Pancreas. 2010;39:36-40. [PMID: 19745777 DOI: 10.1097/mpa.0b013e3181b91cd0] [Cited by in Crossref: 109] [Cited by in F6Publishing: 29] [Article Influence: 9.1] [Reference Citation Analysis]
29 Ammori JB, Do RK, Brennan MF, D'Angelica MI, Dematteo RP, Fong Y, Jarnagin WR, Allen PJ. Uncinate duct dilation in intraductal papillary mucinous neoplasms of the pancreas: a radiographic finding with potentially increased malignant potential. J Gastrointest Surg 2014;18:911-6. [PMID: 24448998 DOI: 10.1007/s11605-014-2449-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
30 Niedergethmann M, Grützmann R, Hildenbrand R, Dittert D, Aramin N, Franz M, Dobrowolski F, Post S, Saeger H. Outcome of Invasive and Noninvasive Intraductal Papillary-Mucinous Neoplasms of the Pancreas (IPMN): A 10-year Experience. World J Surg 2008;32:2253-60. [DOI: 10.1007/s00268-008-9692-8] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 4.2] [Reference Citation Analysis]
31 Suzuki Y, Nakazato T, Yokoyama M, Kogure M, Matsuki R, Abe N, Mori T, Ohkura Y, Sugiyama M. Development and Potential Utility of a New Scoring Formula for Prediction of Malignant Intraductal Papillary Mucinous Neoplasm of the Pancreas. Pancreas 2016;45:1227-32. [DOI: 10.1097/mpa.0000000000000649] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
32 Moris M, Raimondo M, Woodward TA, Skinner V, Arcidiacono PG, Petrone MC, De Angelis C, Manfrè S, Fusaroli P, Wallace MB. Risk factors for malignant progression of intraductal papillary mucinous neoplasms. Digestive and Liver Disease 2015;47:495-501. [DOI: 10.1016/j.dld.2015.03.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
33 Sugiyama M, Suzuki Y, Abe N, Mori T, Atomi Y. Management of intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol. 2008;43:181-185. [PMID: 18373159 DOI: 10.1007/s00535-008-2159-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
34 Baiocchi GL, Portolani N, Grazioli L, Mazza G, Gheza F, Bartoli M, Vanzetti E, Giulini SM. Management of pancreatic intraductal papillary mucinous neoplasm in an academic hospital (2005-2010): what follow-up for unoperated patients? Pancreas. 2013;42:696-700. [PMID: 23160482 DOI: 10.1097/mpa.0b013e318270b98b] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
35 Zhao W, Liu S, Cong L, Zhao Y. Imaging Features for Predicting High-Grade Dysplasia or Malignancy in Branch Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Systematic Review and Meta-Analysis. Ann Surg Oncol 2021. [PMID: 34554343 DOI: 10.1245/s10434-021-10662-2] [Reference Citation Analysis]
36 Eskander MF, Bliss LA, Tseng JF. Pancreatic adenocarcinoma. Current Problems in Surgery 2016;53:107-54. [DOI: 10.1067/j.cpsurg.2016.01.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
37 Nagaike K, Chijiiwa K, Hiyoshi M, Ohuchida J, Kataoka H. Main-duct intraductal papillary mucinous adenoma of the pancreas with a large mural nodule. Int J Clin Oncol 2007;12:388-91. [DOI: 10.1007/s10147-007-0677-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
38 Campbell NM, Katz SS, Escalon JG, Do RK. Imaging patterns of intraductal papillary mucinous neoplasms of the pancreas: an illustrated discussion of the International Consensus Guidelines for the Management of IPMN. Abdom Imaging. 2015;40:663-677. [PMID: 25219664 DOI: 10.1007/s00261-014-0236-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
39 Crippa S, Partelli S, Falconi M. Extent of surgical resections for intraductal papillary mucinous neoplasms. World J Gastrointest Surg 2010; 2(10): 347-351 [PMID: 21160842 DOI: 10.4240/wjgs.v2.i10.347] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
40 Fasanella KE, McGrath K. Cystic lesions and intraductal neoplasms of the pancreas. Best Pract Res Clin Gastroenterol. 2009;23:35-48. [PMID: 19258185 DOI: 10.1016/j.bpg.2008.11.011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
41 Bae SY, Lee KT, Lee JH, Lee JK, Lee KH, Rhee JC. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas. Digestive and Liver Disease 2012;44:257-60. [DOI: 10.1016/j.dld.2011.09.010] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
42 Shimizu Y, Kanemitsu Y, Sano T, Senda Y, Mizuno N, Yamao K. A nomogram for predicting the probability of carcinoma in patients with intraductal papillary-mucinous neoplasm. World J Surg. 2010;34:2932-2938. [PMID: 20845037 DOI: 10.1007/s00268-010-0785-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
43 Takuma K, Kamisawa T, Anjiki H, Egawa N, Kurata M, Honda G, Tsuruta K, Horiguchi S, Igarashi Y. Predictors of malignancy and natural history of main-duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2011;40:371-375. [PMID: 21206326 DOI: 10.1097/mpa.0b013e3182056a83] [Cited by in Crossref: 35] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
44 Nagai K, Doi R, Ito T, Kida A, Koizumi M, Masui T, Kawaguchi Y, Ogawa K, Uemoto S. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Surg. 2009;16:353-358. [PMID: 19280108 DOI: 10.1007/s00534-009-0068-8] [Cited by in Crossref: 86] [Cited by in F6Publishing: 82] [Article Influence: 6.6] [Reference Citation Analysis]
45 Choi SY, Kim JH, Yu MH, Eun HW, Lee HK, Han JK. Diagnostic performance and imaging features for predicting the malignant potential of intraductal papillary mucinous neoplasm of the pancreas: a comparison of EUS, contrast-enhanced CT and MRI. Abdom Radiol (NY) 2017;42:1449-58. [PMID: 28144718 DOI: 10.1007/s00261-017-1053-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
46 Fong ZV, Ferrone CR, Lillemoe KD, Fernández-Del Castillo C. Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current State of the Art and Ongoing Controversies. Ann Surg 2016;263:908-17. [PMID: 26727096 DOI: 10.1097/SLA.0000000000001567] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
47 Pinho DF, Rofsky NM, Pedrosa I. Incidental pancreatic cysts: role of magnetic resonance imaging. Top Magn Reson Imaging. 2014;23:117-128. [PMID: 24690615 DOI: 10.1097/rmr.0000000000000018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
48 Sarr MG, Schnelldorfer T, Reid Lombardo KM, Chari ST. Advances in our understanding of cystic neoplasms of the pancreas. The American Journal of Surgery 2007;194:S100-3. [DOI: 10.1016/j.amjsurg.2007.05.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
49 Genevay M, Mino-Kenudson M, Yaeger K, Konstantinidis IT, Ferrone CR, Thayer S, Castillo CF, Sahani D, Bounds B, Forcione D. Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts. Ann Surg. 2011;254:977-983. [PMID: 22041510 DOI: 10.1097/SLA.0b013e318238] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
50 Shin SS, Armao DM, Shah M, Kim YH, Lee CH, Rubinas T, Brubaker LM, Semelka RC. Management of branch-duct intraductal papillary mucinous neoplasms of the pancreas: observation with MR imaging. Magnetic Resonance Imaging 2010;28:1440-6. [DOI: 10.1016/j.mri.2010.06.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
51 Edirimanne S, Connor SJ. Incidental Pancreatic Cystic Lesions. World J Surg 2008;32:2028-37. [DOI: 10.1007/s00268-008-9633-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 2.5] [Reference Citation Analysis]
52 Kobayashi N, Sugimori K, Shimamura T, Hosono K, Watanabe S, Kato S, Ueda M, Endo I, Inayama Y, Maeda S. Endoscopic ultrasonographic findings predict the risk of carcinoma in branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2012;12:141-145. [PMID: 22487524 DOI: 10.1016/j.pan.2011.12.008] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
53 Huang ES, Turner BG, Fernandez-Del-Castillo C, Brugge WR, Hur C. Pancreatic cystic lesions: clinical predictors of malignancy in patients undergoing surgery. Aliment Pharmacol Ther. 2010;31:285-294. [PMID: 19845568 DOI: 10.1111/j.1365-2036.2009.04173.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
54 Chebib I, Yaeger K, Mino-Kenudson M, Pitman MB. The role of cytopathology and cyst fluid analysis in the preoperative diagnosis and management of pancreatic cysts > 3 cm. Cancer Cytopathol. 2014;122:804-809. [PMID: 25044974 DOI: 10.1002/cncy.21460] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
55 Muniraj T, Aslanian HR, Laine L, Jamidar PA, Farrell JF, Mitchell KA, Salem RR. Resection of pancreatic cystic neoplasms in recurrent acute pancreatitis prevents recurrent pancreatitis but does not identify more malignancies. World J Gastroenterol 2021; 27(15): 1630-1642 [PMID: 33958848 DOI: 10.3748/wjg.v27.i15.1630] [Reference Citation Analysis]
56 Daudé M, Muscari F, Buscail C, Carrère N, Otal P, Selves J, Buscail L, Bournet B. Outcomes of nonresected main-duct intraductal papillary mucinous neoplasms of the pancreas. World J Gastroenterol 2015; 21(9): 2658-2667 [PMID: 25759534 DOI: 10.3748/wjg.v21.i9.2658] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
57 Nissim S, Idos GE, Wu B. Genetic markers of malignant transformation in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis. Pancreas. 2012;41:1195-1205. [PMID: 22750975 DOI: 10.1097/mpa.0b013e3182580fb4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
58 Imaizumi T, Hatori T, Harada N, Fukuda A, Takasaki K, Hanyu F. Intraductal papillary mucinous neoplasm of the pancreas; resection and cancer prevention. The American Journal of Surgery 2007;194:S95-9. [DOI: 10.1016/j.amjsurg.2007.05.020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
59 Couvelard A, Sauvanet A, Kianmanesh R, Hammel P, Colnot N, Lévy P, Ruszniewski P, Bedossa P, Belghiti J. Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluation. Ann Surg. 2005;242:774-778, discussion 778-780. [PMID: 16327487 DOI: 10.1097/01.sla.0000188459.99624.a2] [Cited by in Crossref: 73] [Cited by in F6Publishing: 64] [Article Influence: 4.6] [Reference Citation Analysis]
60 Kanno A, Satoh K, Hirota M, Hamada S, Umino J, Itoh H, Masamune A, Asakura T, Shimosegawa T. Prediction of invasive carcinoma in branch type intraductal papillary mucinous neoplasms of the pancreas. J Gastroenterol. 2010;45:952-959. [PMID: 20383536 DOI: 10.1007/s00535-010-0238-0] [Cited by in Crossref: 74] [Cited by in F6Publishing: 66] [Article Influence: 6.2] [Reference Citation Analysis]
61 Sakorafas GH, Smyrniotis V, Reid-Lombardo KM, Sarr MG. Primary pancreatic cystic neoplasms revisited. Part III. Intraductal papillary mucinous neoplasms. Surg Oncol. 2011;20:e109-e118. [PMID: 21396811 DOI: 10.1016/j.suronc.2011.01.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
62 Clores MJ, Thosani A, Buscaglia JM. Multidisciplinary diagnostic and therapeutic approaches to pancreatic cystic lesions. J Multidiscip Healthc 2014;7:81-91. [PMID: 24520195 DOI: 10.2147/JMDH.S43098] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
63 Akita H, Takeda Y, Hoshino H, Wada H, Kobayashi S, Marubashi S, Eguchi H, Tanemura M, Mori M, Doki Y. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery. Am J Surg. 2011;202:214-219. [PMID: 21376305 DOI: 10.1016/j.amjsurg.2010.06.020] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]
64 Crippa S, Castillo CF. Management of intraductal papillary mucinous neoplasms. Curr Gastroenterol Rep 2008;10:136-43. [DOI: 10.1007/s11894-008-0034-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
65 Ito T, Doi R, Yoshizawa A, Sakikubo M, Nagai K, Kida A, Koizumi M, Masui T, Kawaguchi Y, Manabe T, Uemoto S. The distribution of atypical epithelium in main-duct type intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Sci 2011;18:241-6; discussion 246-9. [PMID: 21165653 DOI: 10.1007/s00534-010-0337-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
66 Blanc B, Sauvanet A, Couvelard A, Pessaux P, Dokmak S, Vullierme MP, Lévy P, Ruszniewski P, Belghiti J. [Limited pancreatic resections for intraductal papillary mucinous neoplasm]. J Chir (Paris) 2008;145:568-78. [PMID: 19106888 DOI: 10.1016/s0021-7697(08)74688-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
67 Karasaki H, Mizukami Y, Tokusashi Y, Koizumi K, Ishizaki A, Imai K, Yoshikawa D, Kino S, Sasajima J, Tanno S, Matsumoto K, Miyokawa N, Kono T, Kohgo Y, Furukawa H. Localization of the Most Severely Dysplastic/Invasive Lesions and Mucin Phenotypes in Intraductal Papillary Mucinous Neoplasm of the Pancreas. Pancreas 2011;40:588-94. [DOI: 10.1097/mpa.0b013e31820d1a03] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
68 Balsarkar D, Takahata S, Tanaka M. Intraductal papillary mucinous neoplasms of the pancreas: is the puzzle solved? Indian J Gastroenterol. 2013;32:213-221. [PMID: 23512214 DOI: 10.1007/s12664-013-0327-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
69 Christopher WO, Earl TM, Puneky LV, Seawright AH, Wynn JJ, Anderson CD, Orr WS. Invasive Pancreatic Adenocarcinoma Arising in Intraductal Papillary Mucinous Neoplasm of Heterotopic Pancreatic Origin Located in the Stomach. The American Surgeon 2017;83:370-1. [DOI: 10.1177/000313481708300911] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
70 Efthymiou A, Podas T, Zacharakis E. Endoscopic ultrasound in the diagnosis of pancreatic intraductal papillary mucinous neoplasms. World J Gastroenterol 2014; 20(24): 7785-7793 [PMID: 24976716 DOI: 10.3748/wjg.v20.i24.7785] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
71 Basturk O, Hong SM, Wood LD, Adsay NV, Albores-Saavedra J, Biankin AV, Brosens LA, Fukushima N, Goggins M, Hruban RH, Kato Y, Klimstra DS, Klöppel G, Krasinskas A, Longnecker DS, Matthaei H, Offerhaus GJ, Shimizu M, Takaori K, Terris B, Yachida S, Esposito I, Furukawa T; Baltimore Consensus Meeting. A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas. Am J Surg Pathol 2015;39:1730-41. [PMID: 26559377 DOI: 10.1097/PAS.0000000000000533] [Cited by in Crossref: 367] [Cited by in F6Publishing: 159] [Article Influence: 61.2] [Reference Citation Analysis]
72 Khannoussi W, Vullierme MP, Rebours V, Maire F, Hentic O, Aubert A, Sauvanet A, Dokmak S, Couvelard A, Hammel P. The long term risk of malignancy in patients with branch duct intraductal papillary mucinous neoplasms of the pancreas. Pancreatology. 2012;12:198-202. [PMID: 22687372 DOI: 10.1016/j.pan.2012.03.056] [Cited by in Crossref: 74] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
73 Sahora K, Fernández-del Castillo C, Dong F, Marchegiani G, Thayer SP, Ferrone CR, Sahani DV, Brugge WR, Warshaw AL, Lillemoe KD, Mino-Kenudson M. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct. Surgery 2014;156:611-21. [PMID: 25081232 DOI: 10.1016/j.surg.2014.04.023] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
74 Harinck F, Bruno M. Endosonography in the management of biliopancreatic disorders. Best Practice & Research Clinical Gastroenterology 2009;23:703-10. [DOI: 10.1016/j.bpg.2009.06.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
75 Gourgiotis S, Ridolfini MP, Germanos S. Intraductal papillary mucinous neoplasms of the pancreas. Eur J Surg Oncol. 2007;33:678-684. [PMID: 17207960 DOI: 10.1016/j.ejso.2006.11.031] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
76 Xiao SY. Intraductal papillary mucinous neoplasm of the pancreas: an update. Scientifica (Cairo) 2012;2012:893632. [PMID: 24278753 DOI: 10.6064/2012/893632] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
77 Tada M, Kawabe T, Arizumi M, Togawa O, Matsubara S, Yamamoto N, Nakai Y, Sasahira N, Hirano K, Tsujino T, Tateishi K, Isayama H, Toda N, Yoshida H, Omata M. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients. Clin Gastroenterol Hepatol. 2006;4:1265-1270. [PMID: 16979953 DOI: 10.1016/j.cgh.2006.07.013] [Cited by in Crossref: 147] [Cited by in F6Publishing: 126] [Article Influence: 9.2] [Reference Citation Analysis]
78 Castillo CF. Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Plea for Prospective Differentiation Between Main-Duct and Side-Branch Tumors. Ann Surg Oncol 2005;12:98-9. [DOI: 10.1245/aso.2005.09.913] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
79 Huang ES, Gazelle GS, Hur C. Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis. Dig Dis Sci 2010;55:852-60. [PMID: 19834805 DOI: 10.1007/s10620-009-1014-y] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
80 Chiu SS, Lim JH, Lee WJ, Chang KT, Oh DK, Lee KT, Lee JK, Choi SH. Intraductal papillary mucinous tumour of the pancreas: differentiation of malignancy and benignancy by CT. Clin Radiol. 2006;61:776-783. [PMID: 16905386 DOI: 10.1016/j.crad.2006.04.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
81 Paini M, Crippa S, Scopelliti F, Baldoni A, Manzoni A, Belfiori G, Partelli S, Falconi M. Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs. Gastroenterol Res Pract 2014;2014:269803. [PMID: 25276122 DOI: 10.1155/2014/269803] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
82 Augustin T, Vandermeer TJ. Intraductal papillary mucinous neoplasm: a clinicopathologic review. Surg Clin North Am 2010;90:377-98. [PMID: 20362793 DOI: 10.1016/j.suc.2009.12.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
83 Takanami K, Hiraide T, Tsuda M, Nakamura Y, Kaneta T, Takase K, Fukuda H, Takahashi S. Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Ann Nucl Med. 2011;25:501-510. [PMID: 21537945 DOI: 10.1007/s12149-011-0494-y] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
84 Goh BK, Tan DM, Ho MM, Lim TK, Chung AY, Ooi LL. Utility of the sendai consensus guidelines for branch-duct intraductal papillary mucinous neoplasms: a systematic review. J Gastrointest Surg 2014;18:1350-7. [PMID: 24668367 DOI: 10.1007/s11605-014-2510-8] [Cited by in Crossref: 63] [Cited by in F6Publishing: 65] [Article Influence: 7.9] [Reference Citation Analysis]
85 Moris M, Raimondo M, Woodward TA, Skinner VJ, Arcidiacono PG, Petrone MC, De Angelis C, Manfrè S, Carrara S, Jovani M, Fusaroli P, Wallace MB. International Intraductal Papillary Mucinous Neoplasms Registry: Long-Term Results Based on the New Guidelines. Pancreas 2017;46:306-10. [PMID: 28099263 DOI: 10.1097/MPA.0000000000000750] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
86 Rafique A, Freeman S, Carroll N. A clinical algorithm for the assessment of pancreatic lesions: utilization of 16- and 64-section multidetector CT and endoscopic ultrasound. Clinical Radiology 2007;62:1142-53. [DOI: 10.1016/j.crad.2007.05.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
87 Kakizaki Y, Makino N, Tozawa T, Honda T, Matsuda A, Ikeda Y, Ito M, Saito Y, Kimura W, Ueno Y. Stromal Fibrosis and Expression of Matricellular Proteins Correlate With Histological Grade of Intraductal Papillary Mucinous Neoplasm of the Pancreas. Pancreas 2016;45:1145-52. [PMID: 26967452 DOI: 10.1097/MPA.0000000000000617] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
88 Mimura T, Masuda A, Matsumoto I, Shiomi H, Yoshida S, Sugimoto M, Sanuki T, Yoshida M, Fujita T, Kutsumi H. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas. J Clin Gastroenterol. 2010;44:e224-e229. [PMID: 20453661 DOI: 10.1097/mcg.0b013e3181d8fb91] [Cited by in Crossref: 56] [Cited by in F6Publishing: 28] [Article Influence: 5.1] [Reference Citation Analysis]
89 Einama T, Kamachi H, Nishihara H, Homma S, Kanno H, Ishikawa M, Kawamata F, Konishi Y, Sato M, Tahara M. Importance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms. Oncol Lett. 2015;9:1583-1589. [PMID: 25789005 DOI: 10.3892/ol.2015.2969] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
90 de Castro SM, Houwert JT, van der Gaag NA, Busch OR, van Gulik TM, Gouma DJ. Evaluation of a selective management strategy of patients with primary cystic neoplasms of the pancreas. Int J Surg. 2011;9:655-658. [PMID: 21925294 DOI: 10.1016/j.ijsu.2011.08.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
91 Buscaglia JM, Shin EJ, Giday SA, Kapoor S, Dunbar KB, Eloubeidi MA, Canto MI, Jagannath SB. Awareness of guidelines and trends in the management of suspected pancreatic cystic neoplasms: survey results among general gastroenterologists and EUS specialists. Gastrointest Endosc 2009;69:813-20, quiz 820.e1-17. [PMID: 18926529 DOI: 10.1016/j.gie.2008.05.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
92 Ball CG, Howard TJ. Natural history of intraductal papillary mucinous neoplasia: How much do we really know? World J Gastrointest Surg 2010; 2(10): 368-372 [PMID: 21160846 DOI: 10.4240/wjgs.v2.i10.368] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
93 Raman SP, Kawamoto S, Blackford A, Hruban RH, O’brien-lennon AM, Wolfgang CL, Rezaee N, Edil B, Fishman EK. Histopathologic Findings of Multifocal Pancreatic Intraductal Papillary Mucinous Neoplasms on CT. American Journal of Roentgenology 2013;200:563-9. [DOI: 10.2214/ajr.12.8924] [Cited by in Crossref: 20] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
94 Vullierme MP, Giraud-Cohen M, Hammel P, Sauvanet A, Couvelard A, O’Toole D, Levy P, Ruszniewski P, Vilgrain V. Malignant intraductal papillary mucinous neoplasm of the pancreas: in situ versus invasive carcinoma surgical resectability. Radiology. 2007;245:483-490. [PMID: 17848678 DOI: 10.1148/radiol.2451060951] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
95 Pitman MB, Michaels PJ, Deshpande V, Brugge WR, Bounds BC. Cytological and cyst fluid analysis of small (& lt; or =3 cm) branch duct intraductal papillary mucinous neoplasms adds value to patient management decisions. Pancreatology. 2008;8:277-284. [PMID: 18497541 DOI: 10.1159/000134276] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 4.9] [Reference Citation Analysis]
96 Adet Caldelari AC, Miquel R, Bombi JA, Ginés À, Fernández-esparrach G, Ayuso JR, Maurel J, Feu F, Castells A, Fernández-cruz L, Navarro S. Factores predictivos de malignidad en la neoplasia mucinosa papilar intraductal de páncreas. Medicina Clínica 2011;137:631-6. [DOI: 10.1016/j.medcli.2010.11.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
97 Ohno E, Itoh A, Kawashima H, Ishikawa T, Matsubara H, Itoh Y, Nakamura Y, Hiramatsu T, Nakamura M, Miyahara R, Ohmiya N, Ishigami M, Katano Y, Goto H, Hirooka Y. Malignant Transformation of Branch Duct–Type Intraductal Papillary Mucinous Neoplasms of the Pancreas Based on Contrast-Enhanced Endoscopic Ultrasonography Morphological Changes: Focus on Malignant Transformation of Intraductal Papillary Mucinous Neoplasm Itself. Pancreas 2012;41:855-62. [DOI: 10.1097/mpa.0b013e3182480c44] [Cited by in Crossref: 64] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
98 Genevay M, Mino-Kenudson M, Yaeger K, Konstantinidis IT, Ferrone CR, Thayer S, Castillo CF, Sahani D, Bounds B, Forcione D, Brugge WR, Pitman MB. Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts. Ann Surg 2011;254:977-83. [PMID: 22041510 DOI: 10.1097/SLA.0b013e3182383118] [Cited by in Crossref: 109] [Cited by in F6Publishing: 30] [Article Influence: 10.9] [Reference Citation Analysis]
99 Carbognin G, Pinali L, Girardi V, Casarin A, Mansueto G, Mucelli RP. Collateral branches IPMTs: secretin-enhanced MRCP. Abdom Imaging. 2007;32:374-380. [PMID: 16967247 DOI: 10.1007/s00261-006-9056-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
100 Sahora K, Crippa S, Zamboni G, Ferrone C, Warshaw A, Lillemoe K, Mino-kenudson M, Falconi M, Fernandez-del Castillo C. Intraductal papillary mucinous neoplasms of the pancreas with concurrent pancreatic and periampullary neoplasms. European Journal of Surgical Oncology (EJSO) 2016;42:197-204. [DOI: 10.1016/j.ejso.2015.10.014] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
101 Yamaguchi T, Baba T, Ishihara T, Kobayashi A, Nakamura K, Tadenuma H, Ito H, Miyazaki M, Saisho H. Long-term follow-up of intraductal papillary mucinous neoplasm of the pancreas with ultrasonography. Clin Gastroenterol Hepatol. 2005;3:1136-1143. [PMID: 16271346 DOI: 10.1016/s1542-3565(05)00756-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
102 Uehara H, Ishikawa O, Ikezawa K, Kawada N, Inoue T, Takakura R, Takano Y, Tanaka S, Takenaka A. A natural course of main duct intraductal papillary mucinous neoplasm of the pancreas with lower likelihood of malignancy. Pancreas. 2010;39:653-657. [PMID: 20173670 DOI: 10.1097/mpa.0b013e3181c81b52] [Cited by in Crossref: 40] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
103 DeWitt J. Endoscopic ultrasound-guided pancreatic cyst ablation. Gastrointest Endosc Clin N Am. 2012;22:291-302, ix-x. [PMID: 22632951 DOI: 10.1016/j.giec.2012.04.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
104 Hanada K, Amano H, Hino F, Fukuda T, Kuroda Y. MANAGEMENT STRATEGIES FOR BRANCH DUCT INTRADUCTAL PAPILLARY-MUCINOUS NEOPLASMS. Dig Endosc 2006;18:S68-72. [DOI: 10.1111/j.1443-1661.2006.00625.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
105 Kim YI, Shin SH, Song KB, Hwang DW, Lee JH, Park KM, Lee YJ, Kim SC. Branch duct intraductal papillary mucinous neoplasm of the pancreas: single-center experience with 324 patients who underwent surgical resection. Korean J Hepatobiliary Pancreat Surg 2015;19:113-20. [PMID: 26379733 DOI: 10.14701/kjhbps.2015.19.3.113] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
106 Bournet B, Buscail L, Escourrou J. Tumeur intracanalaire papillaire mucineuse du pancréas. EMC - Hépatologie 2006;1:1-8. [DOI: 10.1016/s1155-1976(06)40060-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
107 Hoffman RL, Gates JL, Kochman ML, Ginsberg GG, Ahmad NA, Chandrasekhara V, Furth EE, Vollmer CM, Drebin JA. Analysis of Cyst Size and Tumor Markers in the Management of Pancreatic Cysts: Support for the Original Sendai Criteria. Journal of the American College of Surgeons 2015;220:1087-95. [DOI: 10.1016/j.jamcollsurg.2015.02.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
108 Dudeja V, Allen PJ. Premalignant Cystic Neoplasms of the Pancreas. Seminars in Oncology 2015;42:70-85. [DOI: 10.1053/j.seminoncol.2014.12.007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
109 Tsutsumi K, Ohtsuka T, Oda Y, Sadakari Y, Mori Y, Aishima S, Takahata S, Nakamura M, Mizumoto K, Tanaka M. A History of Acute Pancreatitis in Intraductal Papillary Mucinous Neoplasms of the Pancreas Is a Potential Predictive Factor for Malignant Papillary Subtype. Pancreatology 2011;10:707-12. [DOI: 10.1159/000320696] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
110 Rezaee N, Khalifian S, Cameron JL, Pawlik TM, Hruban RH, Fishman EK, Makary MA, Lennon AM, Wolfgang CL, Weiss MJ. Smoking is not associated with severe dysplasia or invasive carcinoma in resected intraductal papillary mucinous neoplasms. J Gastrointest Surg 2015;19:656-65. [PMID: 25477314 DOI: 10.1007/s11605-014-2714-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
111 Buerlein RCD, Shami VM. Management of pancreatic cysts and guidelines: what the gastroenterologist needs to know. Ther Adv Gastrointest Endosc 2021;14:26317745211045769. [PMID: 34589706 DOI: 10.1177/26317745211045769] [Reference Citation Analysis]
112 Gourgiotis S, Germanos S, Ridolfini MP. Presentation and Management of Pancreatic Cystic Neoplasms. Journal of Clinical Gastroenterology 2007;41:599-608. [DOI: 10.1097/01.mcg.0000225684.29841.52] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
113 Fujino Y, Matsumoto I, Ueda T, Toyama H, Kuroda Y. Proposed new score predicting malignancy of intraductal papillary mucinous neoplasms of the pancreas. The American Journal of Surgery 2007;194:304-7. [DOI: 10.1016/j.amjsurg.2006.11.038] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
114 Manfredi R, Graziani R, Motton M, Mantovani W, Baltieri S, Tognolini A, Crippa S, Capelli P, Salvia R, Pozzi Mucelli R. Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis. Radiology. 2009;253:106-115. [PMID: 19703865 DOI: 10.1148/radiol.2531080604] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
115 Miyasaka Y, Nagai E, Ohuchida K, Nakata K, Hayashi A, Mizumoto K, Tsuneyoshi M, Tanaka M. CD44v6 expression in intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2010;39:31-5. [PMID: 19952968 DOI: 10.1097/MPA.0b013e3181c31049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
116 Shimada K, Sakamoto Y, Sano T, Kosuge T, Hiraoka N. Invasive Carcinoma Originating in an Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Clinicopathologic Comparison with a Common Type of Invasive Ductal Carcinoma. Pancreas 2006;32:281-7. [DOI: 10.1097/01.mpa.0000202955.33483.e2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 3.5] [Reference Citation Analysis]
117 Scheiman JM, Hwang JH, Moayyedi P. American gastroenterological association technical review on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology. 2015;148:824-48.e22. [PMID: 25805376 DOI: 10.1053/j.gastro.2015.01.014] [Cited by in Crossref: 208] [Cited by in F6Publishing: 161] [Article Influence: 29.7] [Reference Citation Analysis]
118 Grützmann R, Post S, Saeger HD, Niedergethmann M. Intraductal papillary mucinous neoplasia (IPMN) of the pancreas: its diagnosis, treatment, and prognosis. Dtsch Arztebl Int 2011;108:788-94. [PMID: 22163260 DOI: 10.3238/arztebl.2011.0788] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
119 Park JK, Song BJ, Ryu JK, Paik WH, Park JM, Kim J, Lee SH, Kim YT. Clinical Outcomes of Endoscopic Ultrasonography-Guided Pancreatic Cyst Ablation. Pancreas. 2016;45:889-894. [PMID: 26765962 DOI: 10.1097/mpa.0000000000000567] [Cited by in Crossref: 31] [Cited by in F6Publishing: 11] [Article Influence: 6.2] [Reference Citation Analysis]
120 Lai E, Lau W. Intraductal papillary mucinous neoplasms of the pancreas. The Surgeon 2005;3:317-24. [DOI: 10.1016/s1479-666x(05)80110-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
121 Jamil LH, Chindris AM, Gill KR, Scimeca D, Stauffer JA, Heckman MG, Meek SE, Nguyen JH, Asbun HJ, Raimondo M, Woodward TA, Wallace MB. Glycemic control after total pancreatectomy for intraductal papillary mucinous neoplasm: an exploratory study. HPB Surg 2012;2012:381328. [PMID: 22966212 DOI: 10.1155/2012/381328] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
122 Amini N, Rezaee N, Habib JR, Blair A, Beckman RM, Manos L, Cameron JL, Hruban RH, Weiss MJ, Fishman EK, Zaheer A, Lafaro KJ, Burkhart RA, O'Broin Lennon AM, Burns WR, He J, Wolfgang CL. Minimal main pancreatic duct dilatation in small branch duct intraductal papillary mucinous neoplasms associated with high-grade dysplasia or invasive carcinoma. HPB (Oxford) 2021;23:468-74. [PMID: 32912834 DOI: 10.1016/j.hpb.2020.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
123 Goh B, Tan Y, Cheow P, Chung Y, Chow P, Wong W, Ooi L. Cystic neoplasms of the pancreas with mucin-production. European Journal of Surgical Oncology (EJSO) 2005;31:282-7. [DOI: 10.1016/j.ejso.2004.12.007] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 2.5] [Reference Citation Analysis]
124 Uemura K, Murakami Y, Hayashidani Y, Sudo T, Hashimoto Y, Ohge H, Takesue Y, Arihiro K, Sueda T. Invasive papillary mucinous carcinoma arising in the small branch duct cystic lesion of the pancreas. Pancreas 2006;32:221-2. [PMID: 16552346 DOI: 10.1097/01.mpa.0000202944.78331.da] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
125 Mackey R, Walsh RM. Intraductal Papillary Mucinous Neoplasm With Invasive Carcinoma in the Setting of Chronic Alcoholic Pancreatitis. Pancreas 2007;34:481-3. [DOI: 10.1097/mpa.0b013e3180377bb1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
126 Kim SH, Lee JM, Lee ES, Baek JH, Kim JH, Han JK, Choi BI. Intraductal papillary mucinous neoplasms of the pancreas: evaluation of malignant potential and surgical resectability by using MR imaging with MR cholangiography. Radiology 2015;274:723-33. [PMID: 25302831 DOI: 10.1148/radiol.14132960] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
127 Chang YR, Park JK, Jang JY, Kwon W, Yoon JH, Kim SW. Incidental pancreatic cystic neoplasms in an asymptomatic healthy population of 21,745 individuals: Large-scale, single-center cohort study. Medicine (Baltimore). 2016;95:e5535. [PMID: 28002329 DOI: 10.1097/md.0000000000005535] [Cited by in Crossref: 60] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
128 Yamashita Y, Ueda K, Itonaga M, Yoshida T, Maeda H, Maekita T, Iguchi M, Tamai H, Ichinose M, Kato J. Usefulness of contrast-enhanced endoscopic sonography for discriminating mural nodules from mucous clots in intraductal papillary mucinous neoplasms: a single-center prospective study. J Ultrasound Med. 2013;32:61-68. [PMID: 23269711 DOI: 10.7863/jum.2013.32.1.61] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
129 Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N. Surgical Outcome of Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg Oncol 2007;14:3174-80. [DOI: 10.1245/s10434-007-9546-x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
130 Nagai K, Doi R, Kida A, Kami K, Kawaguchi Y, Ito T, Sakurai T, Uemoto S. Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection. World J Surg. 2008;32:271-278; discussion 279-280. [PMID: 18027021 DOI: 10.1007/s00268-007-9281-2] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 6.8] [Reference Citation Analysis]
131 Tawada K, Ishihara T, Yamaguchi T, Tsuyuguchi T, Hara T, Tada M, Mikata R, Sakai Y, Sugiyama H, Saito M. Comparison of branch duct and main pancreatic duct mural nodules in intraductal papillary mucinous neoplasm. Pancreas. 2013;42:1193-1195. [PMID: 24048461 DOI: 10.1097/mpa.0b013e31828f9725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
132 Katz MH, Mortenson MM, Wang H, Hwang R, Tamm EP, Staerkel G, Lee JH, Evans DB, Fleming JB. Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach. J Am Coll Surg. 2008;207:106-120. [PMID: 18589369 DOI: 10.1016/j.jamcollsurg.2007.12.048] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
133 Ohtsuka T, Kono H, Nagayoshi Y, Mori Y, Tsutsumi K, Sadakari Y, Takahata S, Morimatsu K, Aishima S, Igarashi H, Ito T, Ishigami K, Nakamura M, Mizumoto K, Tanaka M. An increase in the number of predictive factors augments the likelihood of malignancy in branch duct intraductal papillary mucinous neoplasm of the pancreas. Surgery 2012;151:76-83. [DOI: 10.1016/j.surg.2011.07.009] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
134 Uehara H, Abe Y, Kai Y, Takada R, Yamai T, Nakabori T, Ikezawa K, Takahashi H, Ohkawa K. Predictors of malignancy in main duct intraductal papillary mucinous neoplasm of the pancreas. Gastrointest Endosc 2021:S0016-5107(21)01606-0. [PMID: 34474037 DOI: 10.1016/j.gie.2021.08.016] [Reference Citation Analysis]
135 Adsay N, Klimstra D. Pathology and Classification of Pancreatic and Ampullary Tumors. Surgery of the Liver, Biliary Tract and Pancreas. Elsevier; 2007. pp. 829-48. [DOI: 10.1016/b978-1-4160-3256-4.50064-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
136 Fernández-Cruz L, Olvera C, López-Boado MA, Bollo J, Romero J, Comas J. [Organ-preserving resection of the pancreaticoduodenal region in the treatment of intraductal papillary mucinous tumors]. Cir Esp 2006;80:295-300. [PMID: 17192205 DOI: 10.1016/s0009-739x(06)70973-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
137 Satoh K, Hamada S, Kanno A, Hirota M, Umino J, Ito H, Masamune A, Egawa S, Unno M, Shimosegawa T. Expression of MSX2 predicts malignancy of branch duct intraductal papillary mucinous neoplasm of the pancreas. J Gastroenterol 2010;45:763-70. [DOI: 10.1007/s00535-010-0200-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
138 Itoh T, Hirooka Y, Itoh A, Hashimoto S, Kawashima H, Hara K, Kanamori A, Ohmiya N, Niwa Y, Goto H. Usefulness of Contrast-Enhanced Transabdominal Ultrasonography in the Diagnosis of Intraductal Papillary Mucinous Tumors of the Pancreas. Am J Gastroenterology 2005;100:144-52. [DOI: 10.1111/j.1572-0241.2005.40726.x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 43] [Article Influence: 3.5] [Reference Citation Analysis]
139 Matos C, Bali MA, Delhaye M, Devière J. Magnetic resonance imaging in the detection of pancreatitis and pancreatic neoplasms. Best Pract Res Clin Gastroenterol 2006;20:157-78. [PMID: 16473806 DOI: 10.1016/j.bpg.2005.09.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
140 Saito M, Ishihara T, Tada M, Tsuyuguchi T, Mikata R, Sakai Y, Tawada K, Sugiyama H, Kurosawa J, Otsuka M. Use of F-18 fluorodeoxyglucose positron emission tomography with dual-phase imaging to identify intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol. 2013;11:181-186. [PMID: 23142206 DOI: 10.1016/j.cgh.2012.10.037] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
141 Pérez-Cuadrado-Robles E, Uribarri-González L, Borbath I, Vila JJ, López-López S, Deprez PH. Risk of advanced lesions in patients with branch-duct IPMN and relative indications for surgery according to European evidence-based guidelines. Dig Liver Dis 2019;51:882-6. [PMID: 30591368 DOI: 10.1016/j.dld.2018.11.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
142 Nakagawa A, Yamaguchi T, Ohtsuka M, Ishihara T, Sudo K, Nakamura K, Hara T, Denda T, Miyazaki M. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single-detector computed tomography and endoscopic ultrasonography. Pancreas. 2009;38:131-136. [PMID: 18981954 DOI: 10.1097/mpa.0b013e31818b0040] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
143 Gardner TB, Glass LM, Smith KD, Ripple GH, Barth RJ, Klibansky DA, Colacchio TA, Tsapakos MJ, Suriawinata AA, Tsongalis GJ, Pipas JM, Gordon SR. Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults. Am J Gastroenterol 2013;108:1546-50. [PMID: 24091499 DOI: 10.1038/ajg.2013.103] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 8.6] [Reference Citation Analysis]
144 Sahani DV, Lin DJ, Venkatesan AM, Sainani N, Mino-Kenudson M, Brugge WR, Fernandez-Del-Castillo C. Multidisciplinary approach to diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas. Clin Gastroenterol Hepatol. 2009;7:259-269. [PMID: 19121413 DOI: 10.1016/j.cgh.2008.11.008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 3.8] [Reference Citation Analysis]
145 Sauvanet A. Intraductal papillary mucinous neoplasms of the pancreas: indication, extent, and results of surgery. Surg Oncol Clin N Am. 2008;17:587-606, ix. [PMID: 18486885 DOI: 10.1016/j.soc.2008.03.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
146 Paik KY, Choi SH. Experience of limited pancreatic head resection for management of branch duct intraductal papillary mucinous neoplasm in a single center. World J Gastroenterol 2009; 15(23): 2904-2907 [PMID: 19533814 DOI: 10.3748/wjg.15.2904] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
147 Aso T, Ohtsuka T, Ideno N, Kono H, Nagayoshi Y, Mori Y, Ohuchida K, Ueda J, Takahata S, Morimatsu K, Aishima S, Igarashi H, Ito T, Ishigami K, Mizumoto K, Tanaka M. Diagnostic significance of a dilated orifice of the duodenal papilla in intraductal papillary mucinous neoplasm of the pancreas. Gastrointest Endosc. 2012;76:313-320. [PMID: 22658387 DOI: 10.1016/j.gie.2012.03.682] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
148 Sadakari Y, Ienaga J, Kobayashi K, Miyasaka Y, Takahata S, Nakamura M, Mizumoto K, Tanaka M. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas. 2010;39:232-236. [PMID: 19752768 DOI: 10.1097/mpa.0b013e3181bab60e] [Cited by in Crossref: 110] [Cited by in F6Publishing: 40] [Article Influence: 9.2] [Reference Citation Analysis]
149 Megibow AJ. Update in imaging of cystic pancreatic masses for gastroenterologists. Clin Gastroenterol Hepatol 2008;6:1194-7. [PMID: 18848907 DOI: 10.1016/j.cgh.2008.08.026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
150 Schmidt CM, White PB, Waters JA, Yiannoutsos CT, Cummings OW, Baker M, Howard TJ, Zyromski NJ, Nakeeb A, DeWitt JM. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007;246:644-651; discussion 651-654. [PMID: 17893501 DOI: 10.1097/sla.0b013e318155a9e5] [Cited by in Crossref: 300] [Cited by in F6Publishing: 96] [Article Influence: 20.0] [Reference Citation Analysis]
151 Murayama S, Kimura W, Hirai I, Takasu N, Takeshita A, Moriya T. Volumetric and Morphological Analysis of Intraductal Papillary Mucinous Neoplasm of the Pancreas Using Computed Tomography and Magnetic Resonance Imaging. Pancreas 2011;40:876-82. [DOI: 10.1097/mpa.0b013e31821fdcff] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
152 Roggin KK, Chennat J, Oto A, Noffsinger A, Briggs A, Matthews JB. Pancreatic Cystic Neoplasm. Current Problems in Surgery 2010;47:459-510. [DOI: 10.1067/j.cpsurg.2010.02.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
153 Wong J, Weber J, Centeno BA, Vignesh S, Harris CL, Klapman JB, Hodul P. High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound. J Gastrointest Surg. 2013;17:78-84; discussion 84-85. [PMID: 22948841 DOI: 10.1007/s11605-012-2017-0] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 7.3] [Reference Citation Analysis]
154 Sahani DV, Kadavigere R, Blake M, Fernandez-Del Castillo C, Lauwers GY, Hahn PF. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP. Radiology. 2006;238:560-569. [PMID: 16436817 DOI: 10.1148/radiol.2382041463] [Cited by in Crossref: 162] [Cited by in F6Publishing: 140] [Article Influence: 10.1] [Reference Citation Analysis]
155 Ohno E, Hirooka Y, Itoh A, Ishigami M, Katano Y, Ohmiya N, Niwa Y, Goto H. Intraductal papillary mucinous neoplasms of the pancreas: differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ann Surg. 2009;249:628-634. [PMID: 19300203 DOI: 10.1097/sla.0b013e3181a189a8] [Cited by in Crossref: 139] [Cited by in F6Publishing: 47] [Article Influence: 10.7] [Reference Citation Analysis]
156 Hijioka S, Shimizu Y, Mizuno N, Hara K, Imaoka H, Mekky MA, Bhatia V, Nagashio Y, Hasegawa T, Shinagawa A, Sekine M, Tajika M, Tanaka T, Ishihara M, Niwa Y, Yamao K. Can Long-Term Follow-Up Strategies Be Determined Using a Nomogram-Based Prediction Model of Malignancy Among Intraductal Papillary Mucinous Neoplasms of the Pancreas? Pancreas 2014;43:367-72. [DOI: 10.1097/mpa.0000000000000033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
157 Lou W, Jin D, Wang D, Xu X, Kuang T, Qin X. An analysis of clinico-pathologic features of intraductal papillary mucinous neoplasm of the pancreas. Front Med China 2007;1:173-6. [PMID: 24557671 DOI: 10.1007/s11684-007-0032-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
158 Lee KS, Sekhar A, Rofsky NM, Pedrosa I. Prevalence of incidental pancreatic cysts in the adult population on MR imaging. Am J Gastroenterol. 2010;105:2079-2084. [PMID: 20354507 DOI: 10.1038/ajg.2010.122] [Cited by in Crossref: 362] [Cited by in F6Publishing: 326] [Article Influence: 30.2] [Reference Citation Analysis]
159 Laquière A, Lagarde A, Napoléon B, Bourdariat R, Atkinson A, Donatelli G, Pol B, Lecomte L, Curel L, Urena-Campos R, Helbert T, Valantin V, Mithieux F, Buono JP, Grandval P, Olschwang S. Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue. World J Gastroenterol 2019; 25(36): 5530-5542 [PMID: 31576098 DOI: 10.3748/wjg.v25.i36.5530] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
160 Al-Refaie WB, Choi EA, Tseng JF, Tamm EP, Lee JH, Lee JE, Evans DB, Pisters PW. Intraductal papillary mucinous neoplasms of the pancreas. Med Princ Pract. 2006;15:245-252. [PMID: 16763389 DOI: 10.1159/000092985] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
161 Megibow AJ. Pancreatic Neoplasms. Textbook of Gastrointestinal Radiology. Elsevier; 2008. pp. 1915-31. [DOI: 10.1016/b978-1-4160-2332-6.50105-6] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
162 Hwang DW, Jang JY, Lim CS, Lee SE, Yoon YS, Ahn YJ, Han HS, Kim SW, Kim SG, Yun YK, Han SS, Park SJ, Lim TJ, Kang KJ, Sim MS, Choi SH, Heo JS, Choi DW, Hur KY, Lee DS, Yun SS, Kim HJ, Cho CK, Kim HJ, Yu HC, Cho BH, Song IS. Determination of malignant and invasive predictors in branch duct type intraductal papillary mucinous neoplasms of the pancreas: a suggested scoring formula. J Korean Med Sci 2011;26:740-6. [PMID: 21655058 DOI: 10.3346/jkms.2011.26.6.740] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
163 Sakhdari A, Moghaddam PA, Ok CY, Walter O, Tomaszewicz K, Caporelli ML, Meng X, LaFemina J, Whalen G, Belkin E, Zivny J, Wassef W, Woda BA, Hutchinson LM, Cosar EF. Somatic molecular analysis augments cytologic evaluation of pancreatic cyst fluids as a diagnostic tool. Oncotarget 2019;10:4026-37. [PMID: 31258847 DOI: 10.18632/oncotarget.26999] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
164 Sahani DV, Sainani NI, Blake MA, Crippa S, Mino-Kenudson M, del-Castillo CF. Prospective evaluation of reader performance on MDCT in characterization of cystic pancreatic lesions and prediction of cyst biologic aggressiveness. AJR Am J Roentgenol. 2011;197:W53-W61. [PMID: 21700995 DOI: 10.2214/ajr.10.5866] [Cited by in Crossref: 54] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
165 Kawamoto S, Lawler LP, Horton KM, Eng J, Hruban RH, Fishman EK. MDCT of intraductal papillary mucinous neoplasm of the pancreas: evaluation of features predictive of invasive carcinoma. AJR Am J Roentgenol. 2006;186:687-695. [PMID: 16498096 DOI: 10.2214/ajr.04.1820] [Cited by in Crossref: 110] [Cited by in F6Publishing: 29] [Article Influence: 6.9] [Reference Citation Analysis]
166 Ochiai T, Igari K, Furuyama T, Ito H, Mitsunori Y, Aihara A, Kumagai Y, Iida M, Odajima H, Tanaka S, Arii S, Yamazaki S. Favorable response after gemcitabine-radiotherapy for invasive pancreatic intraductal papillary mucinous neoplasm: a case report. Int Surg 2013;98:340-5. [PMID: 24229021 DOI: 10.9738/INTSURG-D-13-00031.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
167 Kim KW, Park SH, Pyo J, Yoon SH, Byun JH, Lee MG, Krajewski KM, Ramaiya NH. Imaging features to distinguish malignant and benign branch-duct type intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Ann Surg. 2014;259:72-81. [PMID: 23657084 DOI: 10.1097/sla.0b013e31829385f7] [Cited by in Crossref: 122] [Cited by in F6Publishing: 41] [Article Influence: 15.3] [Reference Citation Analysis]
168 Ridtitid W, Al-Haddad MA. Endoscopic Ultrasound Imaging for Diagnosing and Treating Pancreatic Cysts. Gastrointest Endosc Clin N Am 2017;27:615-42. [PMID: 28918802 DOI: 10.1016/j.giec.2017.06.004] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
169 Adsay NV. Cystic neoplasia of the pancreas: pathology and biology. J Gastrointest Surg. 2008;12:401-404. [PMID: 17957438 DOI: 10.1007/s11605-007-0348-z] [Cited by in Crossref: 122] [Cited by in F6Publishing: 98] [Article Influence: 8.1] [Reference Citation Analysis]
170 Roch AM, DeWitt JM, Al-Haddad MA, Schmidt CM 2nd, Ceppa EP, House MG, Zyromski NJ, Nakeeb A, Schmidt CM. Nonoperative management of main pancreatic duct-involved intraductal papillary mucinous neoplasm might be indicated in select patients. J Am Coll Surg 2014;219:122-9. [PMID: 24862887 DOI: 10.1016/j.jamcollsurg.2014.03.021] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
171 Tomishima K, Fujisawa T, Fukumura Y, Ushio M, Sato S, Amano N, Murata A, Tsuzura H, Sato S, Matsumoto K, Shimada Y, Genda T, Isayama H. Mucinous Cystadenocarcinoma of the Pancreas with Cyst Infection in a Male Patient. Intern Med 2020;59:2383-9. [PMID: 32999265 DOI: 10.2169/internalmedicine.4937-20] [Reference Citation Analysis]
172 Klibansky DA, Reid-Lombardo KM, Gordon SR, Gardner TB. The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol. 2012;10:555-558. [PMID: 22210438 DOI: 10.1016/j.cgh.2011.12.029] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 8.5] [Reference Citation Analysis]
173 Vullierme M, Giraud M, Hammel P, Couvelard A, Sauvanet A, Belghiti J, Ruszniewski P, Vilgrain V. Aspect radiologique des tumeurs intracanalaires pancréatiques mucineuses et papillaires. Journal de Radiologie 2005;86:781-94. [DOI: 10.1016/s0221-0363(05)81445-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
174 Bournet B, Vignolle-Vidoni A, Grand D, Roques C, Breibach F, Cros J, Muscari F, Carrère N, Selves J, Cordelier P, Buscail L. Endoscopic ultrasound-guided fine-needle aspiration plus KRAS and GNAS mutation in malignant intraductal papillary mucinous neoplasm of the pancreas. Endosc Int Open 2016;4:E1228-35. [PMID: 27995180 DOI: 10.1055/s-0042-117216] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
175 Baiocchi GL, Molfino S, Frittoli B, Pigozzi G, Gheza F, Gaverini G, Tarasconi A, Ricci C, Bertagna F, Grazioli L, Tiberio GA, Portolani N. Increased risk of second malignancy in pancreatic intraductal papillary mucinous tumors: Review of the literature. World J Gastroenterol 2015; 21(23): 7313-7319 [PMID: 26109820 DOI: 10.3748/wjg.v21.i23.7313] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
176 Atiq M, Suzuki R, Khan AS, Krishna SG, Ridgway TM, Guha S, Hernandez LV, Nealon WH, Lee JH, Bhutani MS. Clinical decision making in the management of pancreatic cystic neoplasms. Expert Rev Gastroenterol Hepatol 2013;7:353-60. [PMID: 23639093 DOI: 10.1586/egh.13.23] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
177 Rockacy MJ, Zahid M, McGrath KM, Fasanella KE, Khalid A. Association between KRAS mutation, detected in pancreatic cyst fluid, and long-term outcomes of patients. Clin Gastroenterol Hepatol. 2013;11:425-429. [PMID: 23267865 DOI: 10.1016/j.cgh.2012.12.008] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
178 Takuma K, Kamisawa T, Tabata T, Kurata M, Honda G, Horiguchi S. Main-duct intraductal papillary mucinous adenoma of the pancreas. World J Surg Oncol 2011;9:153. [PMID: 22112163 DOI: 10.1186/1477-7819-9-153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
179 Samarasena JB, Nakai Y, Chang KJ. Endoscopic ultrasonography-guided fine-needle aspiration of pancreatic cystic lesions: a practical approach to diagnosis and management. Gastrointest Endosc Clin N Am. 2012;22:169-185, vii. [PMID: 22632942 DOI: 10.1016/j.giec.2012.04.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
180 Pais SA, Attasaranya S, Leblanc JK, Sherman S, Schmidt CM, DeWitt J. Role of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms: correlation with surgical histopathology. Clin Gastroenterol Hepatol. 2007;5:489-495. [PMID: 17350894 DOI: 10.1016/j.cgh.2006.12.007] [Cited by in Crossref: 87] [Cited by in F6Publishing: 86] [Article Influence: 5.8] [Reference Citation Analysis]
181 Baiocchi GL, Bertagna F, Gheza F, Grazioli L, Calanducci D, Giubbini R, Portolani N, Giulini SM. Searching for indicators of malignancy in pancreatic intraductal papillary mucinous neoplasms: the value of 18FDG-PET confirmed. Ann Surg Oncol. 2012;19:3574-3580. [PMID: 22752369 DOI: 10.1245/s10434-012-2234-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
182 Uehara H, Ishikawa O, Katayama K, Kawada N, Ikezawa K, Fukutake N, Takakura R, Takano Y, Tanaka S, Takenaka A. Size of mural nodule as an indicator of surgery for branch duct intraductal papillary mucinous neoplasm of the pancreas during follow-up. J Gastroenterol 2011;46:657-63. [DOI: 10.1007/s00535-010-0343-0] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 5.0] [Reference Citation Analysis]
183 Palazzo L, O'toole D, Hammel P. Technique of pancreatic cyst aspiration. Gastrointestinal Endoscopy 2009;69:S146-51. [DOI: 10.1016/j.gie.2008.12.041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
184 Nakajima Y, Yamada T, Sho M. Malignant potential of intraductal papillary mucinous neoplasms of the pancreas. Surg Today. 2010;40:816-824. [PMID: 20740343 DOI: 10.1007/s00595-009-4227-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
185 Sawai H, Okada Y, Funahashi H, Matsuo Y, Tanaka M, Manabe T. Immunohistochemical analysis of molecular biological factors in intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas. Scandinavian Journal of Gastroenterology 2009;39:1159-65. [DOI: 10.1080/00365520410003632] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
186 Gomez D, Rahman SH, Wong LF, Verbeke CS, Menon KV. Predictors of malignant potential of cystic lesions of the pancreas. Eur J Surg Oncol 2008;34:876-82. [PMID: 18068941 DOI: 10.1016/j.ejso.2007.11.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
187 Manuel Vázquez A, Carabias Hernández A, Carrascosa Mirón T, Valle Rubio A, Mínguez García J, Sanz Muñoz P, Serantes Gómez A, Jover Navalón JM. What to do with an intraductal papilary mucinous pancreatic neoplasm? Our experience. Cir Esp 2016;94:467-72. [PMID: 27461233 DOI: 10.1016/j.ciresp.2016.05.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
188 Fong ZV, Castillo CF. Intraductal Papillary Mucinous Adenocarcinoma of the Pancreas: Clinical Outcomes, Prognostic Factors, and the Role of Adjuvant Therapy. Viszeralmedizin 2015;31:43-6. [PMID: 26288615 DOI: 10.1159/000373912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
189 Tanaka M. Intraductal Papillary Mucinous Neoplasm of the Pancreas as the Main Focus for Early Detection of Pancreatic Adenocarcinoma. Pancreas. 2018;47:544-550. [PMID: 29702531 DOI: 10.1097/mpa.0000000000001047] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
190 Lee JH, Lee KT, Park J, Bae SY, Lee KH, Lee JK, Jang KT, Heo JS, Choi SH, Choi DW, Rhee JC. Predictive factors associated with malignancy of intraductal papillary mucinous pancreatic neoplasms. World J Gastroenterol 2010; 16(42): 5353-5358 [PMID: 21072900 DOI: 10.3748/wjg.v16.i42.5353] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
191 Bournet B, Kirzin S, Carrère N, Portier G, Otal P, Selves J, Musso C, Suc B, Moreau J, Fourtanier G. Clinical fate of branch duct and mixed forms of intraductal papillary mucinous neoplasia of the pancreas. J Gastroenterol Hepatol. 2009;24:1211-1217. [PMID: 19476563 DOI: 10.1111/j.1440-1746.2009.05826.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
192 Sainani NI, Saokar A, Deshpande V, Fernández-del Castillo C, Hahn P, Sahani DV. Comparative performance of MDCT and MRI with MR cholangiopancreatography in characterizing small pancreatic cysts. AJR Am J Roentgenol. 2009;193:722-731. [PMID: 19696285 DOI: 10.2214/ajr.08.1253] [Cited by in Crossref: 114] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
193 Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang J, Kimura W, Levy P, Pitman MB, Schmidt CM, Shimizu M, Wolfgang CL, Yamaguchi K, Yamao K. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12:183-97. [DOI: 10.1016/j.pan.2012.04.004] [Cited by in Crossref: 1540] [Cited by in F6Publishing: 1233] [Article Influence: 154.0] [Reference Citation Analysis]
194 Mizuno O, Kawamoto H, Yamamoto N, Horiguchi S, Tsutsumi K, Fujii M, Kato H, Hirao K, Kurihara N, Ishida E, Ogawa T, Okada H, Yamamoto K. Single-pattern convergence of K-ras mutation correlates with surgical indication of intraductal papillary mucinous neoplasms. Pancreas 2010;39:617-21. [PMID: 20173673 DOI: 10.1097/MPA.0b013e3181c75d9b] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
195 Kim YI, Woo SM, Lee WJ, Han SS, Park SJ, Kim TH, Koh YH, Hong EK. Appropriate indications of initial endoscopic ultrasound evaluation for detecting mural nodules in branch duct intraductal papillary mucinous neoplasms of the pancreas. Scand J Gastroenterol. 2013;48:610-616. [PMID: 23597152 DOI: 10.3109/00365521.2013.782065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
196 Corcos O, Couvelard A, Dargère D, Sauvanet A, Hammel P, Paradis V, Lévy P, Ruszniewski P, Bedossa P. Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2012;41:169-74. [PMID: 22076567 DOI: 10.1097/MPA.0b013e3182289356] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
197 Ozaki T, Kamura T, Ajioka Y, Shirai Y, Kurosaki I, Yamamoto S, Sasai K. Dynamic computed tomography findings of malignant intraductal papillary mucinous tumor compared with invasive ductal adenocarcinoma. Radiat Med 2007;25:446-52. [PMID: 18026902 DOI: 10.1007/s11604-007-0164-0] [Reference Citation Analysis]
198 Al–haddad M, Schmidt MC, Sandrasegaran K, Dewitt J. Diagnosis and Treatment of Cystic Pancreatic Tumors. Clinical Gastroenterology and Hepatology 2011;9:635-48. [DOI: 10.1016/j.cgh.2011.03.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 4.0] [Reference Citation Analysis]
199 Tsukagoshi M, Araki K, Saito F, Kubo N, Watanabe A, Igarashi T, Ishii N, Yamanaka T, Shirabe K, Kuwano H. Evaluation of the International Consensus Guidelines for the Surgical Resection of Intraductal Papillary Mucinous Neoplasms. Dig Dis Sci. 2018;63:860-867. [PMID: 28667432 DOI: 10.1007/s10620-017-4667-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
200 Käppeli RM, Müller SA, Hummel B, Kruse C, Müller P, Fornaro J, Wilhelm A, Zadnikar M, Schmied BM, Tarantino I. IPMN: surgical treatment. Langenbecks Arch Surg. 2013;398:1029-1037. [PMID: 23999775 DOI: 10.1007/s00423-013-1106-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
201 Petrone MC, Arcidiacono PG. Role of endosocopic ultrasound in the diagnosis of cystic tumours of the pancreas. Dig Liver Dis. 2008;40:847-853. [PMID: 18499542 DOI: 10.1016/j.dld.2008.03.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
202 Ito K, Fujita N, Noda Y, Kobayashi G, Horaguchi J, Takasawa O. CLINICAL SIGNIFICANCE OF INTRADUCTAL ULTRASONOGRAPHY FOR DIAGNOSIS OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM OF THE PANCREAS. Dig Endosc 2006;18:S73-7. [DOI: 10.1111/j.1443-1661.2006.00649.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
203 Takasu N, Kimura W, Moriya T, Takeshita A, Murayama S, Hirai I, Ogata S. A pancreatobiliary-type carcinoma in situ at the periphery of a mural nodule developed from a gastric adenoma in an intraductal papillary mucinous neoplasm. Clin J Gastroenterol 2010;3:209-13. [PMID: 26190249 DOI: 10.1007/s12328-010-0162-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
204 Castelli F, Bosetti D, Negrelli R, Di Paola V, Zantedeschi L, Ventriglia A, Manfredi R, Mucelli RP. Multifocal branch-duct intraductal papillary mucinous neoplasms (IPMNs) of the pancreas: magnetic resonance (MR) imaging pattern and evolution over time. Radiol Med. 2013;118:917-929. [PMID: 23801393 DOI: 10.1007/s11547-013-0945-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
205 Shimizu Y, Yamaue H, Maguchi H, Yamao K, Hirono S, Osanai M, Hijioka S, Kanemitsu Y, Sano T, Senda Y, Bhatia V, Yanagisawa A. Validation of a nomogram for predicting the probability of carcinoma in patients with intraductal papillary mucinous neoplasm in 180 pancreatic resection patients at 3 high-volume centers. Pancreas. 2015;44:459-464. [PMID: 25423557 DOI: 10.1097/mpa.0000000000000269] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
206 Winston C, Teitcher J. Computed tomography of the liver, biliary tract, and pancreas. Blumgart's Surgery of the Liver, Pancreas and Biliary Tract. Elsevier; 2012. pp. 272-312.e4. [DOI: 10.1016/b978-1-4377-1454-8.00016-3] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
207 Paspulati RM. Multidetector CT of the pancreas. Radiol Clin North Am. 2005;43:999-1020, viii. [PMID: 16253659 DOI: 10.1016/j.rcl.2005.07.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
208 Farnell MB. Surgical Management of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas. J Gastrointest Surg 2008;12:414-6. [DOI: 10.1007/s11605-007-0349-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
209 Tomishima K, Sai JK, Kanazawa R, Miura H, Shimizu R, Sato K, Ishii S, Saito H, Ito T, Fukumura Y, Shiina S, Watanabe S. Impact of MUC1 Expression on the Progression of Intraductal Papillary Mucinous Neoplasm With Worrisome Features During Follow-up. Pancreas 2017;46:1127-32. [DOI: 10.1097/mpa.0000000000000902] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
210 Singh M, Maitra A. Precursor lesions of pancreatic cancer: molecular pathology and clinical implications. Pancreatology. 2007;7:9-19. [PMID: 17449961 DOI: 10.1159/000101873] [Cited by in Crossref: 89] [Cited by in F6Publishing: 87] [Article Influence: 5.9] [Reference Citation Analysis]
211 Maguchi H, Tanno S, Mizuno N, Hanada K, Kobayashi G, Hatori T, Sadakari Y, Yamaguchi T, Tobita K, Doi R, Yanagisawa A, Tanaka M. Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan. Pancreas. 2011;40:364-370. [PMID: 21289527 DOI: 10.1097/mpa.0b013e31820a5975] [Cited by in Crossref: 171] [Cited by in F6Publishing: 55] [Article Influence: 15.5] [Reference Citation Analysis]
212 Kato Y, Takahashi S, Gotohda N, Konishi M. Risk Factors for Malignancy in Branched-Type Intraductal Papillary Mucinous Neoplasms of the Pancreas During the Follow-Up Period. World J Surg 2015;39:244-50. [DOI: 10.1007/s00268-014-2789-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
213 Wang W, Zhang L, Chen L, Wei J, Sun Q, Xie Q, Zhou X, Zhou D, Huang P, Yang Q, Xie H, Zhou L, Zheng S. Serum carcinoembryonic antigen and carbohydrate antigen 19-9 for prediction of malignancy and invasiveness in intraductal papillary mucinous neoplasms of the pancreas: A meta-analysis. Biomed Rep. 2015;3:43-50. [PMID: 25469245 DOI: 10.3892/br.2014.376] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 4.4] [Reference Citation Analysis]
214 Pedrosa I, Boparai D. Imaging considerations in intraductal papillary mucinous neoplasms of the pancreas. World J Gastrointest Surg 2010; 2(10): 324-330 [PMID: 21160838 DOI: 10.4240/wjgs.v2.i10.324] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
215 Chung JW, Chung MJ, Park JY, Bang S, Song SY, Chung JB, Park SW. Clinicopathologic features and outcomes of pancreatic cysts during a 12-year period. Pancreas. 2013;42:230-238. [PMID: 23146922 DOI: 10.1097/mpa.0b013e31826ae31a] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
216 Ricci C, Casadei R, Taffurelli G, Zani E, Pagano N, Pacilio CA, Ingaldi C, Bogoni S, Santini D, Migliori M, Di Marco M, Serra C, Calculli L, De Giorgio R, Minni F. Risk Factors for Malignancy of Branch-Duct Intraductal Papillary Mucinous Neoplasms: A Critical Evaluation of the Fukuoka Guidelines With a Systematic Review and Meta-analysis. Pancreas 2016;45:1243-54. [DOI: 10.1097/mpa.0000000000000642] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
217 McCarty TR, Paleti S, Rustagi T. Molecular analysis of EUS-acquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions: a systematic review and meta-analysis.Gastrointest Endosc. 2021;93:1019-1033.e5. [PMID: 33359054 DOI: 10.1016/j.gie.2020.12.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
218 Kawamoto S, Horton KM, Lawler LP, Hruban RH, Fishman EK. Intraductal papillary mucinous neoplasm of the pancreas: can benign lesions be differentiated from malignant lesions with multidetector CT? Radiographics. 2005;25:1451-1468; discussion 1468-1470. [PMID: 16284127 DOI: 10.1148/rg.256055036] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 4.0] [Reference Citation Analysis]
219 Fong ZV, Fernández-del Castillo C. Intraductal Papillary Mucinous Neoplasm of the Pancreas. Surgical Clinics of North America 2016;96:1431-45. [DOI: 10.1016/j.suc.2016.07.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
220 Das A, Ngamruengphong S, Nagendra S, Chak A. Asymptomatic pancreatic cystic neoplasm: a cost-effectiveness analysis of different strategies of management. Gastrointestinal Endoscopy 2009;70:690-699.e6. [DOI: 10.1016/j.gie.2009.02.013] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 3.7] [Reference Citation Analysis]
221 Sharib J, Esserman L, Koay EJ, Maitra A, Shen Y, Kirkwood KS, Ozanne EM. Cost-effectiveness of consensus guideline based management of pancreatic cysts: The sensitivity and specificity required for guidelines to be cost-effective. Surgery 2020;168:601-9. [PMID: 32739138 DOI: 10.1016/j.surg.2020.04.052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
222 Hutchins GF, Draganov PV. Cystic neoplasms of the pancreas: A diagnostic challenge. World J Gastroenterol 2009; 15(1): 48-54 [PMID: 19115467 DOI: 10.3748/wjg.15.48] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
223 Watanabe S, Toki M, Shibahara J, Hisamatsu T. Utility of endoscopic transpapillary pancreatic cyst drainage for intraductal papillary mucinous neoplasm infection. BMJ Case Rep 2021;14:e242583. [PMID: 34088692 DOI: 10.1136/bcr-2021-242583] [Reference Citation Analysis]
224 Grützmann R, Niedergethmann M, Pilarsky C, Klöppel G, Saeger HD. Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. Oncologist. 2010;15:1294-1309. [PMID: 21147870 DOI: 10.1634/theoncologist.2010-0151] [Cited by in Crossref: 70] [Cited by in F6Publishing: 53] [Article Influence: 5.8] [Reference Citation Analysis]
225 Lim LG, Itoi T, Lim WC, Mesenas SJ, Seo DW, Tan J, Wang HP, Akaraviputh T, Lakhtakia S, Omar S. Current status on the diagnosis and management of pancreatic cysts in the Asia-Pacific region: role of endoscopic ultrasound. J Gastroenterol Hepatol. 2011;26:1702-1708. [PMID: 21871024 DOI: 10.1111/j.1440-1746.2011.06884.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
226 Shin SH, Han DJ, Park KT, Kim YH, Park JB, Kim SC. Validating a simple scoring system to predict malignancy and invasiveness of intraductal papillary mucinous neoplasms of the pancreas. World J Surg. 2010;34:776-783. [PMID: 20127242 DOI: 10.1007/s00268-010-0416-5] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
227 Liu Y, Lin X, Upadhyaya M, Song Q, Chen K. Intraductal papillary mucinous neoplasms of the pancreas: Correlation of helical CT features with pathologic findings. European Journal of Radiology 2010;76:222-7. [DOI: 10.1016/j.ejrad.2009.06.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
228 Kirkpatrick IDC, Desser TS, Nino-murcia M, Jeffrey RB. Small cystic lesions of the pancreas: clinical significance and findings at follow-up. Abdom Imaging 2007;32:119-25. [DOI: 10.1007/s00261-006-9080-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
229 Buerke B, Domagk D, Heindel W, Wessling J. Diagnostic and radiological management of cystic pancreatic lesions: important features for radiologists. Clin Radiol. 2012;67:727-737. [PMID: 22520033 DOI: 10.1016/j.crad.2012.02.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
230 Hsiao CY, Yang CY, Wu JM, Kuo TC, Tien YW. Utility of the 2006 Sendai and 2012 Fukuoka guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas: A single-center experience with 138 surgically treated patients. Medicine (Baltimore) 2016;95:e4922. [PMID: 27661043 DOI: 10.1097/MD.0000000000004922] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
231 Shimura T, Kofunato Y, Okada R, Yashima R, Okada K, Araki K, Hosouchi Y, Kuwano H, Takenoshita S. MIB-1 labeling index, Ki-67, is an indicator of invasive intraductal papillary mucinous neoplasm. Mol Clin Oncol 2016;5:317-22. [PMID: 27446570 DOI: 10.3892/mco.2016.908] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
232 Shimizu Y, Yamaue H, Maguchi H, Yamao K, Hirono S, Osanai M, Hijioka S, Hosoda W, Nakamura Y, Shinohara T. Predictors of malignancy in intraductal papillary mucinous neoplasm of the pancreas: analysis of 310 pancreatic resection patients at multiple high-volume centers. Pancreas. 2013;42:883-888. [PMID: 23508017 DOI: 10.1097/mpa.0b013e31827a7b84] [Cited by in Crossref: 84] [Cited by in F6Publishing: 29] [Article Influence: 10.5] [Reference Citation Analysis]
233 Sakorafas GH, Tsiotos GG, Korkolis D, Smyrniotis V. Individuals at high-risk for pancreatic cancer development: management options and the role of surgery. Surg Oncol 2012;21:e49-58. [PMID: 22244849 DOI: 10.1016/j.suronc.2011.12.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
234 Boot C. A review of pancreatic cyst fluid analysis in the differential diagnosis of pancreatic cyst lesions. Ann Clin Biochem. 2014;51:151-166. [PMID: 24097809 DOI: 10.1177/0004563213503819] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
235 Campisi A, Brancatelli G, Vullierme M, Levy P, Ruzniewski P, Vilgrain V. Are pancreatic calcifications specific for the diagnosis of chronic pancreatitis? A multidetector-row CT analysis. Clinical Radiology 2009;64:903-11. [DOI: 10.1016/j.crad.2009.05.005] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
236 Belyaev O, Seelig MH, Muller CA, Tannapfel A, Schmidt WE, Uhl W. Intraductal Papillary Mucinous Neoplasms of the Pancreas. Journal of Clinical Gastroenterology 2008;42:284-94. [DOI: 10.1097/mcg.0b013e3180500761] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
237 Sandrasegaran K, Akisik FM, Patel AA, Rydberg M, Cramer HM, Agaram NP, Schmidt CM. Diffusion-weighted imaging in characterization of cystic pancreatic lesions. Clin Radiol. 2011;66:808-814. [PMID: 21601184 DOI: 10.1016/j.crad.2011.01.016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
238 Kang MJ, Jang JY, Lee S, Park T, Lee SY, Kim SW. Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct. World J Surg. 2015;39:2006-2013. [PMID: 25894399 DOI: 10.1007/s00268-015-3062-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
239 Okabayashi T, Kobayashi M, Nishimori I, Sugimoto T, Namikawa T, Okamoto K, Okamoto N, Kosaki T, Onishi S, Araki K. Clinicopathological features and medical management of intraductal papillary mucinous neoplasms. J Gastroenterol Hepatol. 2006;21:462-467. [PMID: 16509876 DOI: 10.1111/j.1440-1746.2005.03958.x] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 3.3] [Reference Citation Analysis]
240 Nagai K, Doi R, Koizumi M, Masui T, Kawaguchi Y, Yoshizawa A, Uemoto S. Noninvasive intraductal papillary mucinous neoplasm with para-aortic lymph node metastasis: report of a case. Surg Today 2011;41:147-52. [PMID: 21191709 DOI: 10.1007/s00595-009-4210-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
241 Watanabe K, Karasaki H, Mizukami Y, Kawamoto T, Kono T, Imai K, Einama T, Taniguchi M, Kohgo Y, Furukawa H. Cyst Infection of Intraductal Papillary Mucinous Neoplasms of the Pancreas: Management of a Rare Complication Report of 2 Cases. Pancreas 2014;43:478-81. [DOI: 10.1097/mpa.0000000000000036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
242 Nakao A, Fernández-Cruz L. Pancreatic head resection with segmental duodenectomy: safety and long-term results. Ann Surg 2007;246:923-8; discussion 929-31. [PMID: 18043093 DOI: 10.1097/SLA.0b013e31815c2a14] [Cited by in Crossref: 34] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
243 Rosenblatt R, Dorfman V, Epelboym I, Poneros JM, Sethi A, Lightdale C, Woo Y, Gress FG, Allendorf JD, Schrope BA, Chabot JA, Gonda TA. Demographic features and natural history of intermediate-risk multifocal versus unifocal intraductal papillary mucinous neoplasms. Pancreas 2015;44:478-83. [PMID: 25411806 DOI: 10.1097/MPA.0000000000000264] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
244 Mcgrath KM, Krasinskas AM, Federle MP. Intraductal Papillary Mucinous Neoplasia. Gastroenterology Clinics of North America 2007;36:377-90. [DOI: 10.1016/j.gtc.2007.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
245 Kobayashi G, Fujita N, Noda Y, Ito K, Horaguchi J, Obana T, Koshida S, Kanno Y, Yamashita Y, Kato Y. Lateral spread along the main pancreatic duct in branch-duct intraductal papillary-mucinous neoplasms of the pancreas: usefulness of intraductal ultrasonography for its evaluation. Dig Endosc. 2011;23:62-68. [PMID: 21198919 DOI: 10.1111/j.1443-1661.2010.01063.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
246 Trevino JG, Espat NJ, Helton WS. Intraductal papillary mucinous neoplasms of the pancreas. Curr Treat Options Gastroenterol 2006;9:385-90. [PMID: 16942663 DOI: 10.1007/BF02738527] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
247 Qin X, Liu F. The clinicopathologic features of intraductal papillary mucinous neoplasms of the pancreas. Front Med China 2007;1:121-5. [PMID: 24557662 DOI: 10.1007/s11684-007-0023-5] [Reference Citation Analysis]
248 Sauvanet A, Couvelard A, Belghiti J. Role of frozen section assessment for intraductal papillary and mucinous tumor of the pancreas. World J Gastrointest Surg 2010; 2(10): 352-358 [PMID: 21160843 DOI: 10.4240/wjgs.v2.i10.352] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
249 Klöppel G, Basturk O, Schlitter AM, Konukiewitz B, Esposito I. Intraductal neoplasms of the pancreas. Seminars in Diagnostic Pathology 2014;31:452-66. [DOI: 10.1053/j.semdp.2014.08.005] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 6.6] [Reference Citation Analysis]
250 Ceppa EP, Roch AM, Cioffi JL, Sharma N, Easler JJ, Dewitt JM, House MG, Zyromski NJ, Nakeeb A, Schmidt CM. Invasive, mixed-type intraductal papillary mucinous neoplasm: Superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm. Surgery 2015;158:937-45. [DOI: 10.1016/j.surg.2015.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
251 Chiang KC, Hsu JT, Chen HY, Jwo SC, Hwang TL, Jan YY, Yeh CN. Multifocal intraductal papillary mucinous neoplasm of the pancreas-A case report. World J Gastroenterol 2009; 15(5): 628-632 [PMID: 19195068 DOI: 10.3748/wjg.15.628] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
252 Caponi S, Vasile E, Funel N, De Lio N, Campani D, Ginocchi L, Lucchesi M, Caparello C, Lencioni M, Cappelli C. Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms. Eur J Surg Oncol. 2013;39:396-403. [PMID: 23290583 DOI: 10.1016/j.ejso.2012.12.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
253 Satoh K, Hamada S, Shimosegawa T. MSX2 in pancreatic tumor development and its clinical application for the diagnosis of pancreatic ductal adenocarcinoma. Front Physiol 2012;3:430. [PMID: 23162473 DOI: 10.3389/fphys.2012.00430] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
254 Xu MM, Sethi A. Imaging of the Pancreas. Gastroenterol Clin North Am. 2016;45:101-116. [PMID: 26895683 DOI: 10.1016/j.gtc.2015.10.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
255 Wu RI, Yoon WJ, Brugge WR, Mino-kenudson M, Pitman MB. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) contributes to a triple-negative test in preoperative screening of pancreatic cysts: Triple-Negative Test for Pancreatic Cysts. Cancer Cytopathology 2014;122:412-9. [DOI: 10.1002/cncy.21385] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
256 Yoshioka T, Shigekawa M, Yamai T, Suda T, Kegasawa T, Iwahashi K, Ikezawa K, Sakamori R, Yakushijin T, Hiramatsu N. The safety and benefit of pancreatic juice cytology under ERCP in IPMN patients. Pancreatology. 2016;16:1020-1027. [PMID: 27567445 DOI: 10.1016/j.pan.2016.08.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
257 Björk Werner J, Bartosch-härlid A, Andersson R. Cystic pancreatic lesions: Current evidence for diagnosis and treatment. Scandinavian Journal of Gastroenterology 2011;46:773-88. [DOI: 10.3109/00365521.2011.551892] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
258 Murakami Y, Uemura K, Ohge H, Hayashidani Y, Sudo T, Sueda T. Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma. Surgery 2006;140:448-53. [DOI: 10.1016/j.surg.2006.03.017] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.2] [Reference Citation Analysis]
259 Gupta R, Mortelé KJ, Tatli S, Girshman J, Glickman JN, Levy AD, Erturk SM, Heffess CS, Banks PA, Silverman SG. Pancreatic intraductal papillary mucinous neoplasms: role of CT in predicting pathologic subtypes. AJR Am J Roentgenol 2008;191:1458-64. [PMID: 18941085 DOI: 10.2214/AJR.07.3302] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
260 Kwon W, Han Y, Byun Y, Kang JS, Choi YJ, Kim H, Jang JY. Predictive Features of Malignancy in Branch Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Meta-Analysis. Cancers (Basel) 2020;12:E2618. [PMID: 32937809 DOI: 10.3390/cancers12092618] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
261 Pausawasdi N, Heidt D, Kwon R, Simeone D, Scheiman J. Long-term follow-up of patients with incidentally discovered pancreatic cystic neoplasms evaluated by endoscopic ultrasound. Surgery 2010;147:13-20. [DOI: 10.1016/j.surg.2009.05.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
262 Teshima CW, Sandha GS. Endoscopic ultrasound in the diagnosis and treatment of pancreatic disease. World J Gastroenterol 2014; 20(29): 9976-9989 [PMID: 25110426 DOI: 10.3748/wjg.v20.i29.9976] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
263 Haruki K, Wakiyama S, Futagawa Y, Shiba H, Misawa T, Yanaga K. A large mural nodule in branch duct intraductal papillary mucinous adenoma of the pancreas: a case report. Surg Case Rep 2015;1:20. [PMID: 26943388 DOI: 10.1186/s40792-014-0009-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
264 Wada K, Kozarek RA, Traverso LW. Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas. Am J Surg. 2005;189:632-6; discussion 637. [PMID: 15862510 DOI: 10.1016/j.amjsurg.2005.01.020] [Cited by in Crossref: 110] [Cited by in F6Publishing: 106] [Article Influence: 6.5] [Reference Citation Analysis]
265 Do RK, Katz SS, Gollub MJ, Li J, LaFemina J, Zabor EC, Moskowitz CS, Klimstra DS, Allen PJ. Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT. AJR Am J Roentgenol 2014;203:973-9. [PMID: 25341134 DOI: 10.2214/AJR.13.11490] [Cited by in Crossref: 33] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
266 Jang JY, Kim SW, Ahn YJ, Yoon YS, Choi MG, Lee KU, Han JK, Kim WH, Lee YJ, Kim SC. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol. 2005;12:124-132. [PMID: 15827792 DOI: 10.1245/aso.2005.02.030] [Cited by in Crossref: 86] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
267 Walsh RM, Vogt DP, Henderson JM, Hirose K, Mason T, Bencsath K, Hammel J, Brown N. Management of suspected pancreatic cystic neoplasms based on cyst size. Surgery. 2008;144:677-684; discussion 684-685. [PMID: 18847654 DOI: 10.1016/j.surg.2008.06.013] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 4.7] [Reference Citation Analysis]
268 Ogura T, Masuda D, Kurisu Y, Edogawa S, Imoto A, Hayashi M, Uchiyama K, Higuchi K. Potential predictors of disease progression for main-duct intraductal papillary mucinous neoplasms of the pancreas: Potential predictors of malignancy. J Gastroenterol Hepatol 2013;28:1782-6. [DOI: 10.1111/jgh.12301] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
269 Jang JY, Kim SW, Lee SE, Yang SH, Lee KU, Lee YJ, Kim SC, Han DJ, Choi DW, Choi SH. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol. 2008;15:199-205. [PMID: 17909912 DOI: 10.1245/s10434-007-9603-5] [Cited by in Crossref: 123] [Cited by in F6Publishing: 104] [Article Influence: 8.2] [Reference Citation Analysis]
270 Hirono S, Kawai M, Okada K, Miyazawa M, Shimizu A, Kitahata Y, Ueno M, Yanagisawa A, Yamaue H. Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas. Surgery 2016;160:306-17. [DOI: 10.1016/j.surg.2016.04.007] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
271 Burdick JS. Intraductal Papillary Mucinous Neoplasms. Gastrointestinal Endoscopy Clinics of North America 2008;18:523-33. [DOI: 10.1016/j.giec.2008.05.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
272 Kucera JN, Kucera S, Perrin SD, Caracciolo JT, Schmulewitz N, Kedar RP. Cystic lesions of the pancreas: radiologic-endosonographic correlation. Radiographics. 2012;32:E283-E301. [PMID: 23150863 DOI: 10.1148/rg.327125019] [Cited by in Crossref: 39] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
273 Xourafas D, Tavakkoli A, Clancy TE, Ashley SW. Noninvasive intraductal papillary mucinous neoplasms and mucinous cystic neoplasms: recurrence rates and postoperative imaging follow-up. Surgery 2015;157:473-83. [PMID: 25596773 DOI: 10.1016/j.surg.2014.09.028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
274 Handra-Luca A. Blood group type antigens in pancreatic intraductal papillary mucinous neoplasms. Hepatobiliary Pancreat Dis Int 2014;13:74-80. [PMID: 24463083 DOI: 10.1016/s1499-3872(14)60010-2] [Reference Citation Analysis]
275 Einama T, Kamachi H, Sakata T, Shibata K, Wakizaka K, Sugiyama K, Shibuya K, Shimada S, Wakayama K, Orimo T, Yokoo H, Kamiyama T, Mitsuhashi T, Taketomi A. Curative resection of pancreatic ductal adenocarcinoma developing in the remnant pancreas 13 years after distal pancreatectomy for intraductal papillary mucinous neoplasms: A case report. Mol Clin Oncol 2018;8:417-20. [PMID: 29456847 DOI: 10.3892/mco.2018.1556] [Reference Citation Analysis]
276 Fujita M, Itoi T, Ikeuchi N, Sofuni A, Tsuchiya T, Ishii K, Kamada K, Umeda J, Tanaka R, Tonozuka R, Honjo M, Mukai S, Moriyasu F. Effectiveness of contrast-enhanced endoscopic ultrasound for detecting mural nodules in intraductal papillary mucinous neoplasm of the pancreas and for making therapeutic decisions. Endosc Ultrasound. 2016;5:377-383. [PMID: 28000629 DOI: 10.4103/2303-9027.190927] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
277 Reid MD, Bagci P, Adsay NV. Histopathologic assessment of pancreatic cancer: Does one size fit all?: Histopathologic Assessment of Pancreatic Cancer. J Surg Oncol 2013;107:67-77. [DOI: 10.1002/jso.23194] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
278 Sakorafas GH, Sarr MG, van de Velde CJ, Peros G. Intraductal papillary mucinous neoplasms of the pancreas: A surgical perspective. Surgical Oncology 2005;14:155-78. [DOI: 10.1016/j.suronc.2006.01.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
279 Shin SS, Armao DM, Burke LM, Kim HJ, Skrzynia C, Otey CA, Semelka RC. Comparison of the incidence of pancreatic abnormalities between high risk and control patients: Prospective pilot study with 3 tesla MR imaging. J Magn Reson Imaging 2011;33:1080-5. [DOI: 10.1002/jmri.22551] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
280 Roch AM, Ceppa EP, Al-Haddad MA, DeWitt JM, House MG, Zyromski NJ, Nakeeb A, Schmidt CM. The natural history of main duct-involved, mixed-type intraductal papillary mucinous neoplasm: parameters predictive of progression. Ann Surg. 2014;260:680-688; discussion 688-690. [PMID: 25203885 DOI: 10.1097/sla.0000000000000927] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
281 Arlix A, Bournet B, Otal P, Canevet G, Thevenot A, Kirzin S, Carrere N, Suc B, Moreau J, Escourrou J. Long-term clinical and imaging follow-up of nonoperated branch duct form of intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2012;41:295-301. [PMID: 21946814 DOI: 10.1097/mpa.0b013e3182285cc8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
282 Kobayashi G, Fujita N, Noda Y, Obana T, Takasawa O. Ultrasonographic findings and natural history of intraductal papillary-mucinous neoplasms of the pancreas. J Med Ultrason (2001) 2008;35:85-96. [PMID: 27278830 DOI: 10.1007/s10396-008-0188-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
283 Salvia R, Crippa S, Falconi M, Bassi C, Guarise A, Scarpa A, Pederzoli P. Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Gut. 2007;56:1086-1090. [PMID: 17127707 DOI: 10.1136/gut.2006.100628] [Cited by in Crossref: 191] [Cited by in F6Publishing: 179] [Article Influence: 11.9] [Reference Citation Analysis]
284 Sawhney MS, Al-Bashir S, Cury MS, Brown A, Chuttani R, Pleskow DK, Callery MP, Vollmer CM. International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas. Clin Gastroenterol Hepatol. 2009;7:1373-1376. [PMID: 19577006 DOI: 10.1016/j.cgh.2009.06.026] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 3.4] [Reference Citation Analysis]
285 Grenacher L, Klauß M. Computertomographie bei Pankreastumoren. Radiologe 2009;49:107-23. [DOI: 10.1007/s00117-008-1755-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
286 Rodriguez JR, Salvia R, Crippa S, Warshaw AL, Bassi C, Falconi M, Thayer SP, Lauwers GY, Capelli P, Mino-Kenudson M. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology. 2007;133:72-79; quiz 309-310. [PMID: 17631133 DOI: 10.1053/j.gastro.2007.05.010] [Cited by in Crossref: 325] [Cited by in F6Publishing: 281] [Article Influence: 21.7] [Reference Citation Analysis]
287 Lafemina J, Katabi N, Klimstra D, Correa-Gallego C, Gaujoux S, Kingham TP, Dematteo RP, Fong Y, D'Angelica MI, Jarnagin WR, Do RK, Brennan MF, Allen PJ. Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol. 2013;20:440-447. [PMID: 23111706 DOI: 10.1245/s10434-012-2702-y] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 7.3] [Reference Citation Analysis]
288 Tan L, Zhao YE, Wang DB, Wang QB, Hu J, Chen KM, Deng XX. Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi-detector row computed tomography. World J Gastroenterol 2009; 15(32): 4037-4043 [PMID: 19705500 DOI: 10.3748/wjg.15.4037] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]